Literature DB >> 26231569

Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia.

Fumiyuki Yamasaki1, Takeshi Takayasu2, Ryo Nosaka2, Hiroshi Kawaguchi3, Kazuhiko Sugiyama4, Masao Kobayashi3, Kaoru Kurisu2.   

Abstract

PURPOSE: While cavernous angioma (CVA) after cranial irradiation has been documented, its development after high-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) has not. We present a patient with desmoplastic/nodular medulloblastoma (DNMB) associated with anhidrotic ectodermal dysplasia (AED) who developed CVA 2 years after high-dose chemotherapy and PBSCT.
METHODS: A 1-year-old boy with ingravescent vomiting was admitted to our institute. He presented with a large head, a depressed nasal bridge, low-set ears, thick lips with peg-shaped teeth, hypohidrosis, sparse hair, thin atrophic skin, scaly dermatitis with frontal bossing, and a bulging anterior fontanel. Neuroradiological examination revealed multiple cerebellar masses with heterogeneous enhancement and speckled calcifications and severe obstructive hydrocephalus. The histological diagnosis of surgical specimens was DNMB, and he underwent postoperative multiple-drug chemotherapy with autologous PBSCT. The outcome was favorable and he did not undergo radiotherapy.
RESULTS: After 2 years, intracranial hemorrhage was detected at his regular radiological check-up and he again underwent surgery. The histological diagnosis was CVA.
CONCLUSIONS: To our knowledge, this is the first report of AED-associated DNMB and CVA.

Entities:  

Keywords:  Anhidrotic ectodermal dysplasia; Cavernous angioma; Chemotherapy; Medulloblastoma; Peripheral blood stem cell transplantation

Mesh:

Substances:

Year:  2015        PMID: 26231569     DOI: 10.1007/s00381-015-2848-6

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  21 in total

Review 1.  Redefining the target: chemotherapeutics as antiangiogenics.

Authors:  K D Miller; C J Sweeney; G W Sledge
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

2.  Vascular toxicity and the mechanism underlying Raynaud's phenomenon in patients treated with cisplatin, vinblastine and bleomycin.

Authors:  S W Hansen; N Olsen; N Rossing; M Rørth
Journal:  Ann Oncol       Date:  1990-07       Impact factor: 32.976

3.  Augmentation of fibroblast proliferation by bleomycin.

Authors:  P L Moseley; C Hemken; G W Hunninghake
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

4.  Cerebral cavernous malformations. Incidence and familial occurrence.

Authors:  D Rigamonti; M N Hadley; B P Drayer; P C Johnson; K Hoenig-Rigamonti; J T Knight; R F Spetzler
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

Review 5.  Hypohidrotic ectodermal dysplasia.

Authors:  A Clarke
Journal:  J Med Genet       Date:  1987-11       Impact factor: 6.318

6.  Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma.

Authors:  Sean M Lew; Joseph N Morgan; Estee Psaty; Daniel R Lefton; Jeffrey C Allen; Rick Abbott
Journal:  J Neurosurg       Date:  2006-02       Impact factor: 5.115

Review 7.  Ectodermal dysplasias: not only 'skin' deep.

Authors:  M Priolo; M Silengo; M Lerone; R Ravazzolo
Journal:  Clin Genet       Date:  2000-12       Impact factor: 4.438

8.  Vinca alkaloid-induced cardiovascular autonomic neuropathy.

Authors:  E Roca; E Bruera; P M Politi; M Barugel; L Cedaro; S Carraro; R D Chacón
Journal:  Cancer Treat Rep       Date:  1985-02

9.  Incidence of cavernoma development in children after radiotherapy for brain tumors.

Authors:  Sasha Burn; Roxana Gunny; Kim Phipps; Mark Gaze; Richard Hayward
Journal:  J Neurosurg       Date:  2007-05       Impact factor: 5.115

Review 10.  Vascular toxicity associated with antineoplastic agents.

Authors:  D C Doll; J W Yarbro
Journal:  Semin Oncol       Date:  1992-10       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.